| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.37 | 0.02 |